Harvard Bioscience, Inc. (HBIO)
8.46
-0.10
(-1.17%)
USD |
NASDAQ |
Oct 07, 16:00
8.46
0.00 (0.00%)
After-Hours: 18:48
Harvard Bioscience Profit Margin (Quarterly) : -12.80% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.80% |
| March 31, 2026 | -16.50% |
| December 31, 2025 | -11.99% |
| September 30, 2025 | -5.98% |
| June 30, 2025 | -11.16% |
| March 31, 2025 | -231.2% |
| December 31, 2024 | 0.07% |
| September 30, 2024 | -21.86% |
| June 30, 2024 | -12.67% |
| March 31, 2024 | -19.15% |
| December 31, 2023 | -6.46% |
| September 30, 2023 | -4.89% |
| June 30, 2023 | -3.41% |
| March 31, 2023 | 2.08% |
| December 31, 2022 | -5.86% |
| September 30, 2022 | -12.65% |
| June 30, 2022 | 8.34% |
| March 31, 2022 | -23.91% |
| December 31, 2021 | 2.91% |
| September 30, 2021 | -0.57% |
| June 30, 2021 | -1.40% |
| March 31, 2021 | -2.48% |
| December 31, 2020 | -1.98% |
| September 30, 2020 | -4.57% |
| June 30, 2020 | -6.78% |
| Date | Value |
|---|---|
| March 31, 2020 | -19.00% |
| December 31, 2019 | 1.78% |
| September 30, 2019 | -9.56% |
| June 30, 2019 | -0.83% |
| March 31, 2019 | -8.40% |
| December 31, 2018 | 8.17% |
| September 30, 2018 | -0.89% |
| June 30, 2018 | -4.75% |
| March 31, 2018 | -21.86% |
| December 31, 2017 | -0.05% |
| September 30, 2017 | -3.45% |
| June 30, 2017 | -3.25% |
| March 31, 2017 | -4.11% |
| December 31, 2016 | -5.00% |
| September 30, 2016 | -6.55% |
| June 30, 2016 | -2.73% |
| March 31, 2016 | -2.36% |
| December 31, 2015 | -60.42% |
| September 30, 2015 | -3.29% |
| June 30, 2015 | 1.21% |
| March 31, 2015 | -5.44% |
| December 31, 2014 | -0.06% |
| September 30, 2014 | 2.49% |
| June 30, 2014 | 3.79% |
| March 31, 2014 | 2.78% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 19.28% |
| Bio-Rad Laboratories, Inc. | 57.05% |
| Bruker Corp. | -6.07% |
| Danaher Corp. | 13.89% |
| Illumina, Inc. | 17.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -85.35% |
| Return on Assets | -13.27% |
| Return on Invested Capital | -18.61% |
| Gross Profit Margin (Quarterly) | 51.96% |
| Operating Margin (Quarterly) | -2.90% |
| Return on Net Operating Assets | -16.01% |